Jongmyung Kim, MD, PhD

Cancer Focus:
Lung Cancer, Mesothelioma, Thymoma

Dr. Jongmyung Kim is a Radiation Oncologist and Assistant Member in the Department of Radiation Oncology at Moffitt Cancer Center, specializing in the treatment, management, and prevention of lung cancer. His expertise lies in providing top-tier patient care while pioneering innovative theranostic approaches to overcome therapeutic resistance and improve outcomes for patients with advanced or treatment-resistant thoracic cancers. Dr. Kim’s clinical approach emphasizes holistic patient care, addressing the physical and emotional needs of patients. Dr. Kim’s career is marked by his service as a Sergeant in the 8th U.S. Army through the KATUSA (Korean Augmentation to the United States Army) program. He earned his MD-PhD from Pusan National University School of Medicine. After completing the Medical Scientist Training Program, Dr. Kim pursued postdoctoral research on cancer stem cells at the Cleveland Clinic in Ohio, Moffitt Cancer Center, and Rutgers Cancer Institute of New Jersey. He went on to complete a surgical internship at the University of Louisville, followed by a Radiation Oncology residency at Rutgers Cancer Institute of New Jersey/Rutgers Robert Wood Johnson Medical School, where he served as Chief Resident. In his research, Dr. Kim utilizes peptide-directed immuno-radiotherapy and genomics-guided precision oncology, incorporating these strategies into clinical trials to continuously enhance patient-centered care. Alongside his clinical and research endeavors, he is dedicated to mentoring future healthcare professionals. Multiple professional societies have recognized his contributions to oncology. He is the recipient of several prestigious awards, including the 2023 American Society for Radiation Oncology (ASTRO) Recognition Award, the 2023 Korean American Society for Radiation Oncology (KASTRO) Research Grant Award, and the 2022 Radiological Society of North America (RSNA) Roentgen Resident/Fellow Research Award.  

Education & Training

Fellowship:

• Moffitt Cancer Center - Cancer Stem Cell Biology, Department of Neuro-Oncology
• Cleveland Clinic, OH - Cancer Stem Cell Biology, Department of Stem Cell Biology
• Rutgers Cancer Institute of New Jersey - Cancer Biology, Division of Urologic Oncology

Residency:

• Rutgers Cancer Institute of New Jersey - Radiation Oncology

Medical School:

• Pusan National University School of Medicine - MD/PhD

• Sutera P, Kim J, Kumar R, Deek RA, Stephenson R, Mayer T, Saraiya B, Ghodoussipour S, Jang T, Golombos D, Packiam V, Ennis R, Hathout L, Jabbour SK, Guler O, Onal C, Tran PT, Deek MP. PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. Prostate. 2024 Oct.84(14):1301-1308. Pubmedid: 39021052.
• Kim J, Fahmy V, Haffty BG. Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives. Expert Rev Anticancer Ther. 2024 May.24(5):211-217. Pubmedid: 38502143.
• Huang Q, Liu L, Xiao D, Huang Z, Wang W, Zhai K, Fang X, Kim J, Liu J, Liang W, He J, Bao S. CD44+ lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration. Cancer Cell. 2023 Sep.41(9):1621-1636.e8. Pubmedid: 37595587.
• Kim J, Haffty BG. Genetic Factors in the Screening and Imaging for Breast Cancer. Korean J Radiol. 2023 May.24(5):378-383. Pubmedid: 37056158. Pmcid: PMC10157325.
• Potez M, Snedal S, She C, Kim J, Thorner K, Tran TH, Ramello MC, Abate-Daga D, Liu JKC. Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells. Front Oncol. 2023 Mar.13:1124272. Pubmedid: 37035164. Pmcid: PMC10080078.
• Kim J, Mukherji S, Haigentz M, Stubbs VC, Kim S. A rare pattern of local recurrence in the nasopharyngeal carcinoma: Case report. Otolaryngol Case Rep. 2023 Jun.27.
• Kumar R, Kim J, Deek MP, Eskander MF, Gulhati P, In H, Kennedy T, Shah MM, Grandhi MS, Berim L, Spencer KR, Langan RC, Hochster HS, Boland PM, Jabbour SK. Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research. Curr Oncol. 2023 Jul.30(7):6432-6446. Pubmedid: 37504333. Pmcid: PMC10378032.
• Kim J, Potez M, She C, Huang P, Wu Q, Bao S, Rich JN, Liu JKC. Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2. Stem Cells. 2023 Aug.41(8):762-774. Pubmedid: 37280108. Pmcid: PMC10427963.
• Kim J, She C, Potez M, Huang P, Wu Q, Prager BC, Qiu Z, Bao S, Rich JN, Liu JKC. Phage display targeting identifies EYA1 as a regulator of glioblastoma stem cell maintenance and proliferation. Stem Cells. 2021 Jul.39(7):853-865. Pubmedid: 33594762. Pmcid: PMC10741052.
• Lee GT, Kwon SJ, Kim J, Kwon YS, Lee N, Hong JH, Jamieson C, Kim WJ, Kim IY. WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages. Brit J Cancer. 2018 Mar.118(5):670-678. Pubmedid: 29381686. Pmcid: PMC5846063.
• Yu J, Kwon YS, Kim S, Han CS, Farber N, Kim J, Byun SS, Kim WJ, Jeon SS, Kim IY. Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate Cancer. J Urol. 2016 May.195(5):1464-1470. Pubmedid: 26608903. Pmcid: PMC5769700.
• Kim JM, Cho HH, Lee SY, Hong CP, Yang Jw, Kim YS, Suh KT, Jung JS. Role of IRAK1 on TNF-induced proliferation and NF-ĸB activation in human bone marrow mesenchymal stem cells. Cell Physiol Biochem. 2012 Oct.30(1):49-60. Pubmedid: 22759955.
• Kim JM, Yu JM, Bae YC, Jung JS. Analysis of Global Gene Expression Profile of Human Adipose Tissue Derived Mesenchymal Stem Cell Cultured with Cancer Cells. Saengmyeong gwahag hoeji. 2011 May.21(5):631-646.
• Kim JM, Song JS, Cho HH, Shin KK, Bae YC, Lee BJ, Jung JS. Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor. Mol Cell Biochem. 2011 Jan.346(1-2):125-136. Pubmedid: 20890637.
• Cho HH, Shin KK, Kim YJ, Song JS, Kim JM, Bae YC, Kim CD, Jung JS. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol. 2010 Apr.223(1):168-177. Pubmedid: 20049872.

2023 ASTRO Annual Meeting Recognition Award (Biology), American Society for Radiation Oncology

2023 KASTRO Robert Y. Kim MD Annual U.S. Resident/Fellow Research Grant Award, Korean American Society for Radiation Oncology

2022 RSNA Roentgen Fellow/Resident Research Award, Radiological Society of North America